Catalyst

Slingshot members are tracking this event:

PDUFA date for Incyte's(INCY) Ruxolitinib in Graft versus host disease expected May 24, 2019

Source Link:
http://incyte.gcs-web.com/news-releases/news-release-details/incyte-announces-us-fda-has-extended-review-period-ruxolitinib

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
INCY Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
May 24, 2019
Occurred Source:
http://incyte.gcs-web.com/news-releases/news-release-details/fda-approves-jakafir-ruxolitinib-treatment-patients-acute-graft
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Ruxolitinib, Graft Versus Host Disease
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.